A few years ago, drug giant Bristol-Myers Squibb Co. announced it was retooling its strategy, meaning a drug it was developing for insomnia was probably headed for the sidelines. Vanda Pharmaceuticals ...

Chronic insomnia may be caused by a number of factors, including lots of stress, sleep apnea, or acid reflux.

TOKYO, May 28, 2025 - (JCN Newswire) - - Eisai Co., Ltd. announced today that the in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) has been approved in ...

This Nature Outlook is editorially independent, produced with financial support from Avadel. Miranda cannot remember a time in her life when she did not have insomnia. The 23 year old, who asked for ...

But the truth is that sleeping pills like Ambien and Lunesta don't actually improve your sleep much, according to a Consumer Reports Best Buy Drugs analysis, and the newest insomnia medication, ...

"Cannabis and alcohol can help initiate sleep, but regular use may be problematic," the authors of a new study say.

It was found that patients who switched to placebo from suvorexant after 12 months, experienced greater difficulty in falling asleep (14.9 minutes longer) and staying asleep (21.6 minutes less) than ...

If you're struggling to sleep, try a natural sleep aid like melatonin, exercise, meditation, or CBD. And make sure to ...

June 13, 2012 (Boston, Massachusetts) — The investigational dual orexin receptor antagonist suvorexant (Merck) improved sleep onset and maintenance over a 3-month treatment period in 2 pivotal phase 3 ...